Parkinson's, Congressionally Directed Medical Research Programs

Vision – Improve the health and lives of people with Parkinson’s disease through innovative, clinically meaningful treatments

» Click on Image to View Program Booklet

Parkinson's Research Program Overview Image

» Click on Image to View Program Overview

Parkinson’s disease (PD) is a degenerative movement disorder of the central nervous system resulting from a loss of neurons in a region of the brain called the substantia nigra. These neurons produce dopamine, a neurotransmitter important for motor control; however, as PD progresses, the death of dopaminergic neurons results in reduced dopamine levels and impairment of motor control.

For FY22, Congress transitioned the Neurotoxin Exposure Treatment Parkinson’s (NETP) program to the Parkinson’s Research Program (PRP) and broadened the research from neurotoxin exposure treatment PD research to all types of PD research. The PRP challenges the scientific community to develop the most impactful research that will advance the understanding of the disease, with the ultimate goal of ending PD.

For information on toxic exposure research, please go to the Toxic Exposures Research Program at CDMRP.

Congressional Appropriations